Research and Development

Pharmafocus' latest round-up of contract research news includes another CRO heading into private equity hands, changing requirements for the clinicaltrials.gov …

Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …

GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …

Pharmafocus' periodic round-up of developments in the contract research sector includes contracts awarded to Inclinix, Foranep and Phase Forward and …

A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …

The UK has commenced a two-week swine flu vaccine trial, a month ahead of its planned programme to vaccinate 11 …

Quintiles has opened new facilities near Edinburgh, Scotland, that more than double its ability to provide central laboratory services to …

Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …

Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …

 AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …

A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …

UK biotech Renovo is planning to reduce its headcount by over a third after a takeover approach from an unnamed …

Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …

 A change of government would benefit UK pharma, according to the Confederation of British Industry, which says the industry might …

 Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …